Literature DB >> 9365500

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.

A Monks1, D A Scudiero, G S Johnson, K D Paull, E A Sausville.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9365500

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN： 0266-9536


× No keyword cloud information.
  36 in total

1.  Chemosensitivity prediction by transcriptional profiling.

Authors:  J E Staunton; D K Slonim; H A Coller; P Tamayo; M J Angelo; J Park; U Scherf; J K Lee; W O Reinhold; J N Weinstein; J P Mesirov; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

Authors:  Ogechi N Ikediobi; Helen Davies; Graham Bignell; Sarah Edkins; Claire Stevens; Sarah O'Meara; Thomas Santarius; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathan Hinton; Chris Hunter; Andy Jenkinson; David Jones; Vivienne Kosmidou; Richard Lugg; Andrew Menzies; Tatiana Mironenko; Adrian Parker; Janet Perry; Keiran Raine; David Richardson; Rebecca Shepherd; Alex Small; Raffaella Smith; Helen Solomon; Philip Stephens; Jon Teague; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; William Reinhold; John N Weinstein; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Mol Cancer Ther       Date:  2006-11-06       Impact factor: 6.261

3.  Effect of host immunity on metastatic potential in renal cell carcinoma: the assessment of optimal in vivo models to study metastatic behavior of renal cancer cells.

Authors:  Minoru Kobayashi; Tatsuo Morita; Nicole A L Chun; Aya Matsui; Masafumi Takahashi; Takashi Murakami
Journal:  Tumour Biol       Date:  2012-01-05

4.  Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion.

Authors:  Erika Terzuoli; Maura Puppo; Annamaria Rapisarda; Badarch Uranchimeg; Liang Cao; Angelika M Burger; Marina Ziche; Giovanni Melillo
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

5.  A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology.

Authors:  P J Bugelski; U Atif; S Molton; I Toeg; P G Lord; D G Morgan
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

6.  Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines.

Authors:  Constance J Glover; Alfred A Rabow; Yasemin G Isgor; Robert H Shoemaker; David G Covell
Journal:  Biochem Pharmacol       Date:  2006-10-13       Impact factor: 5.858

7.  Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Authors:  Ying Huang; Paul E Blower; Ruqing Liu; Zunyan Dai; Anh-Nhan Pham; Hojin Moon; Jialong Fang; Wolfgang Sadée
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

8.  Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.

Authors:  Angela J Mantha; Kathryn E McFee; Nima Niknejad; Glenwood Goss; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-26       Impact factor: 4.553

9.  Models for prevention and treatment of cancer: problems vs promises.

Authors:  Bharat B Aggarwal; Divya Danda; Shan Gupta; Prashasnika Gehlot
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

10.  Structural similarity assessment for drug sensitivity prediction in cancer.

Authors:  Pavithra Shivakumar; Michael Krauthammer
Journal:  BMC Bioinformatics       Date:  2009-09-17       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.